Novartis

Company overview

Novartis is a Swiss drug maker based in Basel, focused on innovative medicines for heart disease, cancer, immune conditions and brain disorders. Its medicines include the heart failure drug Entresto and the breast cancer treatment Kisqali. It is a leader in advanced treatments that work directly with genetic material, including gene therapy for a rare muscle disease, cell therapies for blood cancers, and RNA medicines that lower cholesterol. These treatments are designed using genetic sequence data. Novartis spun off its generics business as Sandoz in 2023.